Home › Spinal Muscular Atrophy › Arkansas
Spinal Muscular Atrophy clinical trials in Arkansas
3 studies for Spinal Muscular Atrophy are looking for participants at sites in Arkansas.
Cities in Arkansas
ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 4
Ages 2 to 100 · All sexes · Updated Oct 29, 2026 · NCT07448610A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 2
Ages 5 to 17 · All sexes · Updated Oct 8, 2026 · NCT07287982Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
- Arkansas Children's Hospital, Little Rock
RecruitingObservational study
All ages · All sexes · Updated Jan 31, 2025 · NCT04174157From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.